Nova Patents
NO20005508L

5 - ACYLAMINO - 2 - (2-FURYL) - 8 - SUBSTITUTED - PYRAZOLO [4,3-e] - 1,2,4 - TRIAZOLO [1,5-c] PYRIMIDINES AND THEIR PHARMACEUTICAL USE

Abstract

The open formula compound of invention, r, R1, R2, R3, and a manual definition, they are selective adenosine A3 receptor activity. These compounds can be used in drug combinations for the treatment of diseases due to the excessive activity of the A3 receptor, determination or other compounds and combination of the A3 receptor for diagnosis. Invent compounds may be marked, markers can be used for in vitro or in vivo, to determine if there is a high concentration of adenosine A3 receptors of the tumor cells.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

160 members in 56 offices

This recordMember, by publication datePriority claim46 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
15443598United States of AmericaA
37930099United States of AmericaA
9921103United States of AmericaW

Members160

Family members, oldest first
DocumentOfficeKind
CA2332853A1CanadaA1
WO9962495A2World Intellectual Property Organization (WIPO)A2
UY25537A1UruguayA1
AU4090599AAustraliaA
WO9962495A3World Intellectual Property Organization (WIPO)A3
GT199900121AGuatemalaA
CA2332007A1CanadaA1
WO0015231A1World Intellectual Property Organization (WIPO)A1
MA24907A1MoroccoA1
AU6248299AAustraliaA
WO0015231A8World Intellectual Property Organization (WIPO)A8
PE20000626A1PeruA1
WO0015231A9World Intellectual Property Organization (WIPO)A9
PA8474901A1PanamaA1
NO20005508D0NorwayD0
SE0003984D0SwedenD0
IS5706AIcelandA
IS5734AIcelandA
NO20006167D0NorwayD0
LU90687B1LuxembourgB1
SE0003984LSwedenL
GB0027879D0United KingdomD0
AP2000001997A0African Regional Intellectual Property Organization (ARIPO)A0
FI20002367AFinlandA
FI20002367LFinlandL
NO20006167LNorwayL
GB2353527AUnited KingdomA
DK200100432ADenmarkA
EP1082155A2European Patent Office (EPO)A2
NO20005508LThis recordNorwayL
CO5021133A1ColombiaA1
ID28100AIndonesiaA
BR9913766ABrazilA
TR2000003461T2TürkiyeT2
TR2000003611T2TürkiyeT2
TR200003461T2TürkiyeT2
TR200003611T2TürkiyeT2
HK1031696AHong Kong, ChinaA
HK1031696A1Hong Kong, ChinaA1
EA200100007A1Eurasian Patent Organization (EAPO)A1
US6257233B1United States of AmericaB1
CN1303289AChinaA
KR20010071400ARepublic of KoreaA
ID29131AIndonesiaA
CN1312729AChinaA
KR20010089154ARepublic of KoreaA
BR9910931ABrazilA
PL344600A1PolandA1
DE19983530T1GermanyT1
AR018443A1ArgentinaA1
IL139493A0IsraelA0
IL139493D0IsraelD0
HU0102589A2HungaryA2
HUP0102589A2HungaryA2
PL345179A1PolandA1
HK1035671AHong Kong, ChinaA
HK1035671A1Hong Kong, ChinaA1
ZA200101626BSouth AfricaB
HRP20010008A2CroatiaA2
HU0102589A3HungaryA3
HUP0102589A3HungaryA3
IL139791A0IsraelA0
IL139791D0IsraelD0
US2002017297A1United States of AmericaA1
ZA200006920BSouth AfricaB
CH692132A5SwitzerlandA5
HU0103610A2HungaryA2
HUP0103610A2HungaryA2
EE200000721AEstoniaA
US6407236B1United States of AmericaB1
AU749211B2AustraliaB2
BG105113ABulgariaA
SK18162000A3SlovakiaA3
JP2002524519AJapanA
US6448253B1United States of AmericaB1
EG22154AEgyptA
YU76300AYugoslavia, later Serbia and Montenegro (until 2006)A
EA002869B1Eurasian Patent Organization (EAPO)B1
TW509069UTaiwan Province of ChinaU
HU0103610A3HungaryA3
HUP0103610A3HungaryA3
NZ508536ANew ZealandA
US6546929B2United States of AmericaB2
US2003144266A1United States of AmericaA1
NZ509149ANew ZealandA
JP2003527136AJapanA
AU2002305386A1AustraliaA1
US2003209243A1United States of AmericaA1
CA2451081A1CanadaA1
WO03095457A1World Intellectual Property Organization (WIPO)A1
DZ2810A1AlgeriaA1
YU83600AYugoslavia, later Serbia and Montenegro (until 2006)A
IL156851A0IsraelA0
IL156851D0IsraelD0
IL156852A0IsraelA0
IL156852D0IsraelD0
SE522578C2SwedenC2
GB2353527BUnited KingdomB
ES2204262A1SpainA1
IL159594A0IsraelA0
Showing 100 of 160